Medicare lifts limit on brain scans for Alzheimer's patients
Medicare administrators have finalized plans to broaden coverage of PET scans for Alzheimer's patients — a move that potentially boosts the fortunes of promising new antibody treatments like Eisai and Biogen's Leqembi.What happened: The Centers for Medicare and Medicaid Services on Friday lifted a single-test cap on scans for the protein beta-amyloid that's believed to contribute…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Mortgage rates headed to 8 percent territory if Fed keeps up hike pace: Freddie Mac
National MI Partners with TRUE to Advance Digital Mortgage Ecosystem
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News